Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Methotrexate Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
gemcitabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

1 Citation (Scopus)

Association of Combined Modality Therapy vs Chemotherapy Alone with Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma

Jhawar, S. R., Rivera-Núñez, Z., Drachtman, R., Cole, P., Hoppe, B. S. & Parikh, R., May 1 2019, In : JAMA Oncology. 5, 5, p. 689-695 7 p.

Research output: Contribution to journalArticle

Combined Modality Therapy
Hodgkin Disease
Drug Therapy

Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort

Ladas, E. J., Orjuela, M., Stevenson, K., Cole, P., Lin, M., Athale, U. H., Clavell, L. A., Leclerc, J. M., Laverdiere, C., Michon, B., Schorin, M. A., Welch, J. G., Asselin, B. L., Sallan, S. E., Silverman, L. B. & Kelly, K. M., Jan 1 2019, (Accepted/In press) In : Clinical Nutrition.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nutrition Surveys

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group

Kelly, K. M., Cole, P., Pei, Q., Bush, R., Roberts, K. B., Hodgson, D. C., McCarten, K. M., Cho, S. Y. & Schwartz, C., Jan 1 2019, In : British Journal of Haematology.

Research output: Contribution to journalArticle

Hodgkin Disease
Positron-Emission Tomography
Confidence Intervals